The research-based international pharmaceutical company Grünenthal will deploy the PAS-X Process Development package. The group is a leader in the field of pain therapies and invests more than a quarter of its revenues in R&D.
Operating Werum’s PAS-X Process Development, pharmaceutical and biotech companies can simplify and accelerate the modelling of manufacturing processes for pre-clinical and clinical studies.
Grünenthal will initially install the package for substance tracking of clinical batches at its plant in Aachen, Germany.
“With PAS-X Process Development, we are capable of tracking the use and consumption of all raw materials in pharmaceutical development,” said Dr. Martin Lueck, Vice President Head of Pharmaceutical Development & Drug Delivery at Grünenthal. “This enables us to further increase the efficiency of our development activities.”
In addition to PAS-X Process Development, Grünenthal will also deploy the PAS-X business functions Master Batch Records, Warehouse Management and Weighing & Dispensing.
Werum Software & Systems AG, +49 4131 8900-689, dirk.ebbecke@werum.com, www.werum.com.